Watching Wolfson

In 12 years, the UK institute has produced 600 papers, 6 spin-offs, and 31 patents. Does this mean its unique approach is working?

By Stephen Pincock

Related Articles

1 and new details on how a nitric oxide-cGMP-dependent pathway controls mitochondrial biogenesis and the body's energy balance.2,3

The standout feature of the institute is the way it has managed to achieve genuine interaction among researchers of different disciplines, says WIBR collaborator Mary Collins, a researcher based at University College London (UCL). "The interdisciplinary thing is fantastic," she says. "Getting medicinal chemists alongside biologists is quite hard to do in academia."

WIBR founder Salvador Moncada
© Calum Macintosh Courtesy of WIBR

Jim Smith, director of the Gurdon Institute at the University of Cambridge, agrees. "It's a terrific idea to bring together groups in fields that normally don't speak to one another," he says. "That sort of interaction is where...

Interested in reading more?

Magaizne Cover

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?